ConductScience.org, home

Paper42909412PubMed

Reconstructing the Tumor Mechanical Microenvironment in Organoids: From Mechanical Cues to Biomimetic Modeling and Therapeutic Insights.

Yan S and 5 others. Int J Med Sci, 2026.

Cite this record

ConductScience Library. Reconstructing the Tumor Mechanical Microenvironment in Organoids: From Mechanical Cues to Biomimetic Modeling and Therapeutic Insights. Papers, record 42909412. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42909412

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Reconstructing the Tumor Mechanical Microenvironment in Organoids: From Mechanical Cues to Biomimetic Modeling and Therapeutic Insights.
Journal
Int J Med Sci
Year
2026
Publication types
Journal Article, Review
Revised in PubMed
2026-10-24

Source PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yan SShuying
2Zhu JJing
3Oliveira JMJoaquim M
4Reis RLRui L
5Yan LLeping
6Xiao LLin

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Tumor MicroenvironmentMajor topic
OrganoidsMajor topic
NeoplasmsMajor topic
BiomimeticsMajor topic
Humans
Extracellular Matrix
Animals
Models, Biological
Bioprinting
Coculture Techniques

Source PubMed

Download CSV of topics

References185

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136226506Enabling perfusion through multicellular tumor spheroids promoting lumenization in a vascularized cancer model.Lab Chip2022https://conductscience.org/library/papers/36226506PubMed
230771534ROCK isoforms differentially modulate cancer cell motility by mechanosensing the substrate stiffness.Acta Biomater2019https://conductscience.org/library/papers/30771534PubMed
338238471Linking cell mechanical memory and cancer metastasis.Nat Rev Cancer2024https://conductscience.org/library/papers/38238471PubMed
434106045Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment.Elife2021https://conductscience.org/library/papers/34106045PubMed
541389968Ultrasound-responsive Pickering emulsions enable extracellular matrix disruption for enhanced sonodynamic immunotherapy.J Control Release2026https://conductscience.org/library/papers/41389968PubMed
639622151Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy.Transl Oncol2025https://conductscience.org/library/papers/39622151PubMed
738071145Converging bioprinting and organoids to better recapitulate the tumor microenvironment.Trends Biotechnol2024https://conductscience.org/library/papers/38071145PubMed
841882003Extracellular matrix rigidity controls breast cancer metastasis via TYK2-mediated mechanotransduction.Nat Commun2026https://conductscience.org/library/papers/41882003PubMed
931063753The Extracellular Matrix Modulates the Metastatic Journey.Dev Cell2019https://conductscience.org/library/papers/31063753PubMed
1037508373Solute Transport across the Lymphatic Vasculature in a Soft Skin Tissue.Biology (Basel)2023https://conductscience.org/library/papers/37508373PubMed
1122622799Interstitial fluid pressure as an alternate regulator of angiogenesis independent of hypoxia driven HIF-1α in solid tumors.J Orthop Res2012https://conductscience.org/library/papers/22622799PubMed
1230647431Modelling cancer in microfluidic human organs-on-chips.Nat Rev Cancer2019https://conductscience.org/library/papers/30647431PubMed
1338992411Quantitative atlas of collagen hydrogels reveals mesenchymal cancer cell traction adaptation to the matrix nanoarchitecture.Acta Biomater2024https://conductscience.org/library/papers/38992411PubMed
1433008910Peptide-protein coassembling matrices as a biomimetic 3D model of ovarian cancer.Sci Adv2020https://conductscience.org/library/papers/33008910PubMed
1540324810Unlocking the power of immune checkpoint inhibitors: Targeting YAP1 reduces anti-PD1 resistance in skin cutaneous melanoma.Br J Pharmacol2025https://conductscience.org/library/papers/40324810PubMed
1635119068The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer.Clin Sci (Lond)2022https://conductscience.org/library/papers/35119068PubMed
1741141582Hydrogel delivering antifibrotic agent and nano-sonosensitizer enhances efficacy of sonodynamic therapy in osteosarcoma treatment.Bioact Mater2026https://conductscience.org/library/papers/41141582PubMed
1828520521Three-Dimensional Cell Cultures in Drug Discovery and Development.SLAS Discov2017https://conductscience.org/library/papers/28520521PubMed
1939793891ECM stiffness regulates lung fibroblast survival through RasGRF1-dependent signaling.J Biol Chem2025https://conductscience.org/library/papers/39793891PubMed
2039461060Matrix stiffening from collagen fibril density and alignment modulates YAP-mediated T-cell immune suppression.Biomaterials2025https://conductscience.org/library/papers/39461060PubMed

See all 185 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42909412

GET https://conductscience.org/api/papers/v1/42909412/references?page=2